Multitarget Stool DNA Test Performance in an Average-Risk Colorectal Cancer Screening Population

We set out to evaluate the performance of a multitarget stool DNA (MT-sDNA) in an average-risk colonoscopy-controlled colorectal cancer (CRC) screening population. MT-sDNA stool test results were evaluated against fecal immunochemical test (FIT) results for the detection of different lesions, including molecularly defined high-risk adenomas and several other tumor characteristics.Whole stool samples (n = 1,047) were prospectively collected and...